SCHEMBL7738147

SCHEMBL7738147

O=C(CN1CCCCC1)Nc1ccc(C2CCCCC2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.81
NPC1 O15118 4/20 0.81
HPGD P15428 2/20 0.81
USP2 O75604 2/20 0.81
KDM4E B2RXH2 4/20 0.62
THRB P10828 1/20 0.62
HTT P42858 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
TP53 P04637 1/20 0.59
RAB9A P51151 1/20 0.59
POLB P06746 2/20 0.59
GAA P10253 1/20 0.59
MAPT P10636 1/20 0.59
RAD52 P43351 1/20 0.59
HRH3 Q9Y5N1 2/20 0.58
MITF O75030 1/20 0.58
KLF5 Q13887 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738167 0.89 ALDH1A1 (1.00) ALDH1A1NPC1HPGDUSP2HRH3
SCHEMBL7735984 0.85 ALDH1A1 (0.67) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL7735928 0.85 ALDH1A1 (0.71) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL7735766 0.82 SMN1; SMN2 (0.64) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL8155606 0.81 SMN1; SMN2 (0.81) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL7736314 0.81 ALDH1A1 (0.62) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL7736310 0.81 ALDH1A1 (0.61) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL3305614 0.81 ALDH1A1 (0.61) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL7726594 0.81 ALDH1A1 (0.61) ALDH1A1NPC1HPGDUSP2KDM4E
SCHEMBL14537720 0.80 TSHR (0.75) ALDH1A1NPC1HPGDUSP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410792-B1 OBESITY DISEASES BAYER CORPORATION 2002-06-25 US disclosed
US-6048900-A FOR TREATING EATING DISORDERS, INSULIN RESISTANT DIABETES, HYPERTENSION, HYPERLIPEMIA BAYER CORPORATION (US) 2000-04-11 US disclosed
EP-0910565-A1 AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Bayer Corporation (US) 1999-04-28 EP disclosed
WO-1998035957-A1 AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BAYER CORPORATION (US) 1998-08-20 WO disclosed